PROTHAMBIN GENE MUTATION

Prothrombin gene mutation, assessed through the diagnostic services provided by Hypro Diagnostics, is not an isolated disease but rather a blood clotting disorder. This genetic variation triggers an overproduction of prothrombin, a key clotting protein, thereby increasing the likelihood of abnormal blood clot formation. The heightened risk of blood clots, particularly in the lungs or deep veins of the legs, underscores the importance of precise diagnostic evaluation. Hypro Diagnostics plays a crucial role in identifying and monitoring this condition, allowing for proactive management to reduce potential complications and ensure optimal health outcomes.